New TIDI Glove Products Added to Novation Contract
TIDI Products LLC, a manufacturer of single-use infection prevention products for medical and dental markets, has added three new gloves to its Novation LLC contract. The gloves include the 18 mil P2® HiRisk Latex Exam Gloves, 15 mil P2® SafetyPlus Latex Exam Gloves, and the 8 mil P2® Nitrile Exam Gloves.
The three gloves are use in high risk applications such as sterile processing/decontamination and chemotherapy drug compounding and administration. The 18 mil and 8 mil gloves are chemotherapy tested per the ASTM Standard D6978-05.
The existing contract, which began Nov. 1, 2010, runs through Oct. 31, 20111. The glove addition to the contract will complete Novations current offer to members for nitrile, vinyl and latex gloves.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.
